young and feeble in some areas, old and consolidated in others: the fundamental human rights and their political projection, the democratic system. The third level discussed below, the existential/religious, still creates difficulties however, for a national, or a European, ethical consensus.
Because scientific innovations appear at a high rate in medicine, societies have to counteract tendencies both to apathy and to legal prohibition as the only public reactions. The last decades have shown that democratic bodies such as parliaments can deal with medical-ethical problems, although often in an inappropriate way because they are not used to dealing with the concepts relevant to medical ethics.
The three levels
In the preceding section it was stated that three levels of interactions would be analysed. The first is the inter-personal level. In medical ethics this is exemplified by the patient-doctor relationship and the patient-researcher relationship. The interpersonal level deals with the individually named patient, in a concrete situation, with a named doctor or researcher as partner. Its most personal components are those usually confined to the nonprofessional private sphere: for example, politeness, respect, symmetry in dialogue, and information. But it also comprises the projected elements of national laws, for example: health legislation relating to the duties of health personnel, and criminal law relating to the citizen's protection against forceful intrusion by other citizens, including health personnel.
The second level of medical ethics is the personstate-level. This comprises the laws that set standards for the medical aspects of a health system serving citizens as a whole. Examples are the legal definition of death, access to major organ transplantations, access to non-selective and selective abortion, distribution of scarce health resources, and human experimentation.
The third level is the existential/religious level of medical ethics, comprising the application of medical methods (or even the deliberate non-application), and involving man in a deeper existential context. Examples are: research on fertilised human eggs; the right to die without further medical intervention; in some countries the right to die by the aid of a medical intervention; and, for members of certain religious communities, the mere existence of laws permitting free and selective abortion.
The intra-and international variation of norms and legislations on these three levels is substantial, even in Europe. The greatest variation is in the third level. Different religious beliefs, Catholic, Islamic, Jewish, Lutheran, to say nothing of the strong antibelief movements ( German parents from such consideration is a typical example of an 'escapist export' of an ethical problem. Fortunately this export has now stopped because of new law legitimising brain death.
The fourth type of public reaction, the acceptance of a public debate and of citizens' co-responsibility, is fortunately becoming more common. Such debate takes time; and time can be made a general political excuse for not making decisions.
Major areas of European medical ethics I will now discuss four major areas of European medical ethics which will need to be a focus for debate over the next decade.
1) European research ethics committees
Despite a general European consensus on the importance of research ethics, and despite the general acceptance of the Second Helsinki Declaration on the ethics of medical research, and the demand of the declaration, that 'the experimental protocol should be transmitted to a specially appointed independent committee for consideration, comment and guidance', committee systems of Europe differ very considerably. Some countries have a nationwide system built up in accordance with fixed rules for membership, functions etc. Some countries have created a legal base for such committees, others have left it to individual institutions to establish local committees. Accordingly, the range of variation is formidable.
The number of committees in each country varies from less than ten, as in Norway and Denmark, to several hundreds in countries without a co-ordinated national system.
The membership varies from an overwhelming number of scientists with one, or a few, lay members, to parity between lay and scientific members (even to a slight preponderance of lay members, as is the case in the Danish law of October 1, 1992) .
Some committees are only institutional, others cover all biomedical research, within medicine, odontology and pharmacy, of an area, being by constitution regional. The first type can leave projects from general practice of medicine and dentistry uncovered, the latter comprises all biomedical research, whether in practice, industry, research institutions or hospitals.
Some national systems are single-tiered, others are double-tiered. In the first case national co-ordination of decisional levels and norms is difficult, often exemplified in the way that multi-centre trials are dealt with. In a single-tiered system appeal mechanisms are often not formalised, and hearings of the national system for political reasons are difficult and often yield multi-tongued answers. Research projects in Third World countries, supported by Povl Riis 9
European governments or granting bodies, are also difficult to bring into a single-tiered system, in order to ensure the necessary research-ethical standard of such projects.
In some countries non-scientific committee members must be 'lay specialists', for example lawyers, theologians, philosophers; in others such members must be true lay members, ie truly representative of a democratic system.
THE NECESSARY CO-ORDINATION OF EUROPEAN ETHICS COMMITTEE SYSTEMS
The co-ordination, and even harmonisation, of the European research-ethical committees, is an urgent task. The great variation in committee membership and functions emphasises the difficulties of such, much needed, co-ordination. It is not primarily a question of linking existing systems together, but of creating national systems in a way that makes a European system possible. In the EC guidelines on European pharmacological research (1), an 'ethics committee' is defined as follows: 'An independent body, constituted by medical professionals and nonmedical members, whose responsibility is to verify that the safety, integrity and human rights of the subjects participating in a particular trial are protected, thereby providing public reassurance.
'Ethics committees should be constituted and operated so that the suitability of the investigators, facilities, protocols, the eligibility of trial subject groups, and the adequacy of confidentiality safeguards may be objectively and impartially reviewed independently of the investigator, sponsor, and relevant authorities. ' The legal status, constitution, and regulatory requirements pertaining to ethics committees, review boards, or similar institutions may differ among countries.
'A list of the members, and their positions, of the ethics committee and a description of its working procedures including response times should be publicly available. ' As will be seen the guidelines do not specify the kind of national system needed for a co-ordinated European system. The necessary next step must be a description of, at least, the minimal requirements for a national committee system. If not, European multi-centre studies will be ethically uneven. Furthermore, unless a co-ordinated system is developed, the present unsatisfactory situation will continue, viz 
2) Democratic health systems
The most important ethical problem to be faced over the next few years is that of distributional ethics, ie how health resources should be distributed in a fair way to those in need. Two aspects of this central ethical problem will need to be considered. The first is the necessity for a public health system which gives all citizens access to health care, not unlimited access, but access representing a fair share of the total national health resources.
Systems which are based mainly or completely on private insurance schemes leave those most in need either with nothing or to charity. Such systems can never achieve the degree of fairness which is necessary for them to be ethically legitimate in a democratic society.
The second aspect of distributional ethics derives from the fact that even countries with a democratic health system face scarcity. The limited resources need to be distributed fairly. Health systems have never had the ability to cover all need, if all possibilities were exploited, but only recently has this fact become apparent to the public and to the health professions. The continuous flow of new therapeutic possibilities, for example major organ transplantation, intra-temporal computer-assisted devices for the totally deaf and joint alloplasties, has made the economic-ethical dilemma visible to all. Handling the distribution-ethical problem is one of the greatest challenges for the future. It will require us to step back from our own interests in order to help those citizens who are in greater need than ourselves.
PATIENTS' RIGHTS AND DUTIES
Although the patient-doctor relationship has come a long way from the extreme paternalism which once characterised it, many patients are still not accorded their full rights to respect, information and selfdetermination. This is not only because of doctors' and nurses' attitudes, but is also due to a lack of knowledge and abilities on the part of the health care professionals. To inform patients on technical matters, for instance, presupposes the mastering of a non-professional language, which is precise and does not 'infantilise' the patient.
Increasing respect for patients' rights has to take place on several levels. This issue needs to be tackled early in the training of health profession students both directly in the systematic part of their learning, and indirectly through the implicit and explicit attitudes of their teachers. Fighting prejudices, such as paternalistic attitudes, must also take place early in professional development, at best before any prejudices are laid down. Further, the postgraduate climate in hospitals and other institutions needs to include an overall acceptance of patients' rights. And finally, administrative instructions from health departments and health legislation must directly address this aim. It will not be sufficient for there to be debate; or for a few pioneers to set new standards: administration directives with legal backing will be necessary in order to change behaviour in all parts of a health system.
Having reached a general acceptance of patients' rights one can add the complementary demand: that of patients' duties towards the health system. For instance, patients should respect health personnel's right to have personal beliefs, should treat such personnel decently as the fellow citizens they are, and should comply with agreements (or in case of force majeure should inform) etc. This complementarity, yet asymmetry in the patient/health-professional relationship, needs to be acknowledged more openly in the future.
3) The ethics of the human genome project
Europe is strongly involved in the ongoing endeavours to map the complete human genome. This enterprise has both fascinated and scared the public. The fears have centred around the hypothetical grouping of mankind into alpha-, beta-etc types, and the application of such knowledge to, for example the selection of personnel for polluting and dangerous industries (ie selecting those most resistant to industrial diseases), or to the exclusion of those considered 'bad risks' from insurance schemes. Some of the fears of this kind might be turned to promises. Why not welcome the possibility that a baker's apprentice could, if he wished, be tested for genes leading to flour allergy? As for the fascination, it is possible that the unearthing of the formidable genetic variation which exists amongst a population will help to emphasise the necessity of not confusing equity and dignity with an individual's genes and capabilities. In this way the genome project may help to foster an attitude which emphasises the fundamental equality of human beings and not the opposite.
4) When to stop treatment?
Although the ability to preserve life has been a central aim for health care now, when we have access to highly effective life-sustaining techniques, we see the opposite side of the coin: the sustaining of life beyond what seems of value. The appearance of 'The right to die' movement and the introduction of legislation concerning brain death are signs of a new duality in dealing with life-sustaining methods: at the same time they are both a blessing and a curse.
At present, national policies concerning the proper use of life-sustaining techniques vary widely. In some countries there is no guidance; in others there is discussion about whether living wills should be given legal backing. In Holland voluntary euthanasia is openly (although still illegally) practised. Closely co-operating nations need to pool their efforts in clarifying the necessary basic concepts, and in performing the necessary research on diagnostic safety in different terminal states, with the common aim of ensuring that citizens are, on the one hand confident that they will not be treated absurdly without consideration of their personal wishes and quality of life and, on the other hand that they can rely on hospitals not to function as a state sorting-mechanism of unrightful lives.
The necessary debate
Information on, and public discussions of, ethical aspects of health services and health sciences are characterised by their discontinuous, almost stochastic nature. In this way medical ethics shares the fate of existential and religious topics in the public media. Where one would very much wish an ongoing debate, describing the many ethical dilemmas in medicine with all their pros and cons, one gets instead long periods of silence and then A necessary larger perspective will, for instance, mean acknowledging the fundamental difference between understanding connections stepwise and piecemeal (to know some of the twigs, but not the tree) and understanding full connections in a long leap (to see the tree, but not to know all the twigs).
It will further mean acknowledging the fundamental difference between the concept of reward or quid pro quo closely related to merits, and the concept of benefit unrelated to merits, ie possessing the nature of a gift. In accordance with the latter concept individual human beings are judged not by their merits, but are allocated an identical and unalienable value.
The acknowledgements mentioned would force man to act on two different levels: 1) That of day-today necessity, where the stepwise understanding and the correlation between reward and merits rule, and 2) that of an intellect-independent total pattern, where the value of individuals is independent of talents and merits. On the first level one operates with degrees of perfection, on the other with degrees of imperfection, where a general forgiveness is the principal answer to imperfection.
This complicated dualism can be illustrated through an analogy with the nature of music. It is impossible to grasp the total message of emotions and insight that a given piece of music holds through a stepwise acquisition of individual bars' tonal geometry and the individual instruments' functioning. It will need a formidable cultural revolution of our European societies in order to face these existential questions and to take a stand other than the usual attitude of playing the winner. 
